OTC : SNNUF

Smith & Nephew plc

$15.48 USD

$0 (0.0%)

Volume
300
Average Volume
1.47K
Market Capitalization
$13B
P/E Ratio
19.76
Dividend Yield
2.61%
Price Target
Year High
$18.50
Year Low
$13.10
Day High
—
Day Low
—
Payout Ratio
$0.52
Current Ratio
$2.14
Company Overview

OTC

Deepak S. Nath

Medical - Devices

Healthcare

SNNUF

18362

GB

USD

https://www.smith-nephew.com

44 1923 477 100

83175M205

0000845982

Liquidity Metrics

0.73

2.14

1.11

0.37

0.52

Sales & Valuation

$6.3B

1.98

2.45

14.88

1.00

Profitability

$0.73

$638.9M

10.08%

12.65%

12.25%

5.81%

P/E Metrics

19.76

0.59

0.59

Analyst Price Target & Rating

Neutral

3/5

17 Analysts

%

Financial Health Scores

3.95

8/9

$2.33B

$11B

$5.83B

$1.83B

Key Metrics (TTM)

$15.66B

2.46

9.44

2.14

12.25%

8.85%

5.04%

6.72%

$10.22

244 days

Company Executives
Name Title
Helen Barraclough Group General Counsel & Company Secretary
Ajay Dhankhar Chief Corporate Development & Strategy Officer
John Terence Rogers Chief Financial Officer & Executive Director
Charles Reynolds Head of Corporate Communication
Emily Heaven Head of Investor Relations
Deepak S. Nath Chief Executive Officer & Director
Vasant Padmanabhan President Research & Development, ENT and Emerging Markets
Paul Connolly President of Global Operations
Alison Parkes Chief Compliance Officer & Compliance APAC
Elga Lohler Chief Human Resources Officer
Poll Results

No votes yet today — be the first to share your view!

About Smith & Nephew plc (OTC:SNNUF) Stock

Smith & Nephew plc is a global medical technology enterprise dedicated to the development, manufacturing, and worldwide commercialization of an extensive array of medical devices. Its product portfolio spans several key areas. In orthopedics, the company provides knee implants for replacement procedures, hip implants for joint reconstruction, and trauma and extremities products, including both internal and external fixation devices, crucial for stabilizing severe fractures and correcting deformities. For sports medicine, Smith & Nephew offers joint repair solutions tailored for surgeons. This includes specialized instruments, advanced technologies, and implants essential for minimally invasive joint surgeries, targeting soft tissue injuries and degenerative conditions of the knee, hip, and ... shoulder, as well as meniscal repair systems. Additionally, the firm supplies arthroscopic enabling technologies that enhance surgical visualization and intervention within joints. This suite encompasses fluid management equipment for surgical access, high-definition cameras, digital imaging capture systems, scopes, light sources, and monitors. It also features radiofrequency, electromechanical, and mechanical tissue resection devices, alongside hand instruments for precise tissue removal. The company also provides dedicated ear, nose, and throat (ENT) solutions. Its Advanced Wound Management division delivers comprehensive solutions for the treatment and prevention of acute and chronic wounds, covering conditions like leg, diabetic, and pressure ulcers, burns, and post-operative wounds. This segment includes advanced wound bioactives, comprising biologics and other bioactive technologies for debridement, dermal repair, and regeneration. Regenerative medicine products, such as skin, bone graft, and articular cartilage substitutes, are also offered. Furthermore, Smith & Nephew provides advanced wound devices, including traditional and single-use negative pressure wound therapy systems, and hydrosurgery technology. Primarily serving healthcare providers globally, Smith & Nephew plc was founded in 1856 and is headquartered in Watford, United Kingdom.

Frequently Asked Questions

What is the current Smith & Nephew plc (SNNUF) stock price?

Smith & Nephew plc(OTC:SNNUF) stock price is $15.48 in the last trading session. During the trading session, SNNUF stock reached the peak price of $18.5 while $13.1 was the lowest point it dropped to. The percentage change in SNNUF stock occurred in the recent session was 0.0% while the dollar amount for the price change in SNNUF stock was $0.

SNNUF's industry and sector of operation?

The OTC listed SNNUF is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of SNNUF?

Helen Barraclough | Group General Counsel & Company Secretary
Ajay Dhankhar | Chief Corporate Development & Strategy Officer
John Terence Rogers | Chief Financial Officer & Executive Director
Charles Reynolds | Head of Corporate Communication
Emily Heaven | Head of Investor Relations

How many employees does SNNUF have?

Number of SNNUF employees currently stands at 18362. SNNUF operates from Building 5, Watford, HR WD18 8YE, GB.

Link for SNNUF official website?

Official Website of SNNUF is: https://www.smith-nephew.com

How do I contact SNNUF?

SNNUF could be contacted at phone #44 1923 477 100 and can also be accessed through its website. SNNUF operates from Building 5, Watford, HR WD18 8YE, GB.

How many shares of SNNUF are traded daily?

The average number of SNNUF shares traded daily for last 3 months was 1.47K.

What is the market cap of SNNUF currently?

The market value of SNNUF currently stands at $13B with its latest stock price at $15.48